A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor

od Kelly, Ciara M., Shoushtari, Alexander N., Qin, Li-Xuan, D’Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal M., Keohan, Mary Louise, Mcfadyen, Chloe, Sjoberg, Ana, Singer, Samuel, DeMatteo, Ronald P., Hwang, Sinchun, Heinemann, M.H., Francis, Jasmine H., Antonescu, Cristina R., Chi, Ping, Tap, William D.
Izdano u Invest New Drugs (2018)

Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab

od D'Angelo, Sandra P., Shoushtari, Alexander N., Keohan, Mary Louise, Dickson, Mark A., Gounder, Mrinal M., Chi, Ping, Loo, Jennifer K., Gaffney, Leigh, Schneider, Lee, Patel, Zarine, Erinjeri, Joseph Patrick, Bluth, Mark J., Sjoberg, Ana, Streicher, Howard, Takebe, Naoko, Qin, Li-Xuan, Antonescu, Cristina, DeMatteo, Ronald P., Carvajal, Richard D., Tap, William D.
Izdano u Clin Cancer Res (2016)